blend45MG
Tri-Heal
45MG Protocol
Tri-Heal 45MG
Injection Freq.
Inject once daily
Cycle Sched.
8–12 weeks; optional extension to 16 weeks
Reconstitution
3.0 mL BAC water
Supports tissue repair and wound healing via complementary pathways
Promotes angiogenesis and cell migration (TB‑500)
Supports tendon/muscle/gut repair signaling (BPC‑157)
Anti‑inflammatory cytokine modulation (KPV)
1
Reconstitution Requirements
- 3.0 mL BAC water
Escalation steps: 4
Defined through week 8
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–2 | 500 mcg | 3.3 |
| 2 | Weeks 3–4 | 1000 mcg | 6.7 |
| 3 | Weeks 5–6 | 1500 mcg | 10 |
| 4 | Weeks 7–8 | 2000 mcg | 13.3 |
Inject once daily
8–12 weeks; optional extension to 16 weeks
Tri-Heal combines three peptides that target different bottlenecks in the repair process so the overall response is broader than any single agent. TB-500 (thymosin β4) is described as a pro‑repair factor that supports cell migration and new blood‑vessel formation while dampening inflammatory signaling and apoptotic stress in injured tissue. BPC‑157 is presented as a cytoprotective, pro‑angiogenic peptide that influences nitric‑oxide and growth‑factor pathways to support fibroblast activity and structural rebuilding in tendon, muscle, and gut tissues. KPV, a short α‑MSH–derived fragment, is included primarily for anti‑inflammatory control; it is noted for reducing NF‑κB activity and downstream cytokine signaling in epithelial/immune contexts. In combination, the blend aims to (1) keep inflammation in check, (2) improve local perfusion via angiogenesis, and (3) accelerate remodeling of damaged soft tissue—i.e., repair + circulation + inflammatory restraint in one protocol.
Occasional mild injection‑site redness or irritation
Transient discomfort at injection site
Limited human clinical safety data for the full combination
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)